Pathologic Response to Preoperative Chemotherapy in Colorectal Liver Metastases: Fibrosis, not Necrosis, Predicts Outcome

Significance of Acellular Mucin Pools in Rectal Carcinoma After Neoadjuvant Chemoradiotherapy

(2010) Jinru Shia et al.   AMERICAN JOURNAL OF SURGICAL PATHOLOGY

Bevacizumab Improves Pathological Response of Colorectal Cancer Liver Metastases Treated with XELOX/FOLFOX

(2010) Markus Klinger et al.   ANNALS OF SURGICAL ONCOLOGY

Extended Preoperative Chemotherapy Does Not Improve Pathologic Response and Increases Postoperative Liver Insufficiency After Hepatic Resection for Colorectal Liver Metastases

(2010) Yoji Kishi et al.   ANNALS OF SURGICAL ONCOLOGY

Predictors of a true complete response among disappearing liver metastases from colorectal cancer after chemotherapy

(2010) Rebecca C. Auer et al.   CANCER

Conversion to Resectability Using Hepatic Artery Infusion Plus Systemic Chemotherapy for the Treatment of Unresectable Liver Metastases From Colorectal Carcinoma

(2009) Nancy E. Kemeny et al.   JOURNAL OF CLINICAL ONCOLOGY

Complete Pathologic Response After Preoperative Chemotherapy for Colorectal Liver Metastases: Myth or Reality?

(2008) René Adam et al.   JOURNAL OF CLINICAL ONCOLOGY

Pathologic Response to Preoperative Chemotherapy: A New Outcome End Point After Resection of Hepatic Colorectal Metastases

(2008) Dan G. Blazer et al.   JOURNAL OF CLINICAL ONCOLOGY

Assessing the optimal duration of chemotherapy in patients with colorectal liver metastases

(2008) Rebekah R. White et al.   JOURNAL OF SURGICAL ONCOLOGY

Perioperative chemotherapy with FOLFOX4 and surgery versus surgery alone for resectable liver metastases from colorectal cancer (EORTC Intergroup trial 40983): a randomised controlled trial

(2008) Bernard Nordlinger et al.   LANCET

Colorectal liver metastases contract centripetally with a response to chemotherapy

(2007) Jennica K.S. Ng et al.   CANCER